Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues-Reference-Cited by-同舟云学术

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues

Published:2017-11-30 Issue:11 Volume:12 Page:e0188303
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Broquetas Teresa^ORCID,Garcia-Retortillo Montserrat,Hernandez Juan José,Puigvehí Marc,Cañete Nuria,Coll Susana,Cabrero Beatriz,Giménez Maria Dolors,Solà Ricard,Carrión José A.

Funder

Instituto de Salud Carlos III (ES)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities;S Boucle;Clinics in liver disease,2016

2. Natural history of chronic hepatitis B REVEALed;CJ Chen;J Gastroenterol Hepatol,2011

3. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response;HL Chan;Clin Gastroenterol Hepatol,2007

4. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective;J Jaroszewicz;J Hepatol,2010

5. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers;MR Brunetto;Gastroenterology,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Past, present, and future of long-term treatment for hepatitis B virus;World Journal of Gastroenterology;2023-07-07

2. Effect of entecavir plus peginterferon α-2a on hepatitis B virus-RNA, IL-21 expression level, immune function and prognosis in patients with hepatitis B;Materials Express;2023-04-01

3. Clinical Consequences of Hepatitis B Surface Antigen Loss in Chronic Hepatitis B Infection: A Systematic Literature Review and Meta-Analysis;Gastro Hep Advances;2023

4. On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty;Digestive and Liver Disease;2022-08

5. Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus;Hepatic Medicine: Evidence and Research;2022-07